This article focuses on summarizing the regulatory developments related to cosmetics within China and internationally in November 2024, with an emphasis on updates in China new cosmetic ingredient notifications, cosmetic administrative penalty, official FAQs and so on.
In November 2024, 6 new cosmetic ingredients were filed with the China National Medical Products Administration (NMPA). They include:
|
Ingredient Name in CN & EN |
Notification No. |
Notifier in CN |
|
金花茶（CAMELLIA CHRYSANTHA）叶提取物 |
20240074 |
广州华玺生物科技有限公司 |
|
二氢杨梅素 |
20240075 |
广东芭薇生物科技股份有限公司 |
|
青钱柳（CYCLOCARYA PALIURUS）叶提取物 |
20240076 |
上海家化联合股份有限公司 |
|
翠云草（SELAGINELLA UNCINATA） |
20240077 |
云南贝泰妮生物科技集团股份有限公司 |
|
二乙二醇苯醚 |
20240078 |
艾米泰生物科技（上海）有限公司 |
|
金耳（TREMELLA AURANTIALBA）子实体提取物 |
20240079 |
凡可生物技术（广州）有限公司 |
The technical requirements for the 6 new cosmetic ingredients mentioned above have not been disclosed, and they have not yet entered the monitoring period.
In November 2024, four NCI were canceled. Among them, three ingredients were explicitly noted as being "managed as existing cosmetic ingredients," while one ingredient had no related remarks.
On November 4, 2024, China's National Medical Products Administration (NMPA) approved a new cosmetic ingredient, Isobutylamido Thiazolyl Resorcinol (Thiamidol 630), marking the first ingredient registered since the implementation of Cosmetic Supervision and Administration Regulation (CSAR) in 2021. See previous report.
On November 8, 2024, the National Center Adverse Drug Reaction Monitoring, China (Center for Drug Reevaluation, NMPA) issued a notice soliciting public comments on the Guidelines for Cosmetic Registrants and Notifiers in Writing A Self-inspection Report on Cosmetic Adverse Reactions (Trial) (Draft for Comments). The deadline for submitting comments is December 6, 2024.
On November 8, 2024, the Ministry of Health and Welfare of Taiwan issued announcement No. 1131608487, revising the Guidelines for Risk Assessment of Cosmetics Containing Nanomaterials. Key updates include the formulation basis and the definition of cosmetics containing nanomaterials, with nanomaterials defined as having a size range of 1 to 100 nanometers. The risk assessment method is divided into two parts: physicochemical property analysis and safety evaluation. See official announcement.
On November 15, 2024, the Chinese National Institutes for Food and Drug Control (NIFDC) released a notice to solicit public comments on Ingredient Usage Information of Marketed Products ( Revised Draft for Comments). This Draft introduces several updates, including an expanded scope, the incorporation of reference principles, higher permissible usage levels, and an increase in plant-derived ingredients. See previous report.
On November 12, 2024, the Ministry of Health and Welfare of Taiwan issued announcement No. 1131608175 and amended regulations, revising the List of Cosmetic Categories and Types. The revision is set to officially take effect on July 1, 2026. See official announcement.
On November 15, 2024, the National Institutes for Food and Drug Control (NIFDC) in China released the FAQs on Technical Cosmetic Safety Assessment (Vol.1). It addresses two key issues: determining the toxicological endpoints required for ingredient evaluation and the conditions for exempting phototoxicity and photoallergenicity assessments for cosmetic ingredients.
Form November 15 to 19, China NIFDC published a set of frequently asked questions to clarify common issues encountered during cosmetic technical reviews. The topics addressed include product formulations, implementation standards, cosmetic labeling, and requirements for special cosmetics. See previous report.
On November 19, 2024, Guangzhou Medical Products Administration issued the 68th "FAQs on the Registration of General Cosmetics," providing detailed explanations regarding pH control indicators, efficacy ingredient control indicators in cosmetic product standards.
On the same day, the Bureau also published the 69th "FAQs on the Registration of General Cosmetics," addressing issues related to bitter nail polish products designed to deter children from thumb-sucking and labeling claims involving target user groups.
On November 28, 2024, Guangzhou Medical Products Administration issued the 70th "FAQs on the Registration of General Cosmetics," focusing specifically on the cosmetic safety assessment system. It clarified how the system is being implemented smoothly and highlighted its significance.
On November 21, 2024, the Beijing Medical Products Administration issued "FAQs on the Registration of General Cosmetics" (Vol. 39), addressing questions related to cosmetic preservative challenge testing, including the purpose of preservative challenge tests and the reference documents for filing entities when conducting such tests.
On November 22, 2024, the General Administration of Customs published a list of non-compliant imported cosmetics from October 2024, which included 5 batches all from South Korea. Two batches of freeze-dried powders were rejected for discrepancies between the goods and their certificate. The remaining three batches failed due to the presence of acrylamide not meeting national standards.
On November 7, 2024, the European Union's Scientific Committee on Consumer Safety (SCCS) issued a preliminary opinion (SCCS/1672/24) on Benzophenone-1 (CAS No. 131-56-6). Deadline for comments is January 13, 2025. See official announcement.
On November 12, 2024, the European Union's Scientific Committee on Consumer Safety (SCCS) released a preliminary scientific opinion (SCCS/1671/24) on Ethylhexyl Methoxycinnamate (EHMC) (CAS No. 5466-77-3/83834-59-7, EC No. 226-775-7/629-661-9) . Deadline for comments is 17 January 2025. See official announcement.
Recently, Indonesia's National Agency of Drug and Food Control (BPOM) announced that it had seized 16 aesthetic products that were falsely labeled as cosmetics. These products, which actually involved the use of needles and microneedles for injection, violated the regulatory definitions of cosmetics. According to BPOM Regulation No. 21 of 2022, cosmetics are only for external use on specific parts of the human body, and products that involve needle or microneedle injections are not classified as cosmetics. BPOM head Taruna Ikrar stated that this action is a result of strengthened regulatory oversight of cosmetics distribution from September 2023 to October 2024.
On November 5, 2024, Indonesia BPOM released a draft of Technical Requirements for Cosmetic Good Manufacturing Practices (GMP) Certification. The key proposed amendments
include:
Define the following terms: Cosmetic Good Manufacturing Practices Certification (CPKB), Cosmetic Good Manufacturing Practices Certificate (CPKB Certificate), Commercial Identification Number (NIB), and CPKB Aspects Compliance Certificate.
Method for applying for CPKB: online application and verification through the official website.
Conditions that companies must meet to apply for CPKB.
The cosmetics industry must manufacture products in forms approved by the Food and Drug Administration (BPOM) and listed in the CPKB Certificate or CPKB Aspects Compliance Certificate. If other forms are used, a new CPKB application must be submitted.
The CPKB Certificate or CPKB Aspects Compliance Certificate is valid for five years from the date of renewal issuance.
Renewal and amendment details for the certificate.
The feedback period for this revision ends on November 18, 2024. See official announcement.
On November 17, 2024, the Saudi Food and Drug Authority (SFDA) established import requirements for cosmetics and ingredients, effective immediately. The main provisions include:
Relevant Definitions
Scope of Application: Applies to all cosmetics, semi-finished products, and ingredients.
Customs Clearance Requirements: Applications for customs clearance must be submitted electronically via the FASAH platform. The original customs clearance documents must be retained for at least five years. Required submission details include: manufacturer name and country of origin, invoice number and date, product name, product batch number or production date, and certificate of conformity (signed before shipment).
Note: This article is compiled by ZMUni Compliance Centre, drawing from the latest updates from official regulatory authorities in various countries and regions. For any questions regarding interpretations or expressions, please consult the official real-time announcements.
